Cargando…

Targeting H(i)ck education for cancer therapy?

Detalles Bibliográficos
Autores principales:	Ernst, Matthias, O'Donoghue, Robert J.J., Poh, Ashleigh R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769969/ https://www.ncbi.nlm.nih.gov/pubmed/29344543 http://dx.doi.org/10.18632/oncoscience.388

Ejemplares similares

Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells
por: Poh, Ashleigh R., et al.
Publicado: (2015)

Mouse models for gastric cancer: Matching models to biological questions
por: Poh, Ashleigh R, et al.
Publicado: (2016)

Recognising the benefits and harms of breast cancer screening: an opportunity to target improvement
por: O'Donoghue, C, et al.
Publicado: (2013)

Targeting Macrophages in Cancer: From Bench to Bedside
por: Poh, Ashleigh R., et al.
Publicado: (2018)

Synthetic DNA and RNA Programming
por: O’Donoghue, Patrick, et al.
Publicado: (2019)

Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities
por: Poh, Ashleigh R., et al.
Publicado: (2023)

An intrasplenic injection model of pancreatic cancer metastasis to the liver in mice
por: O’Brien, Megan, et al.
Publicado: (2023)

The APC/C and CK1 in the developing brain
por: Penas, Clara, et al.
Publicado: (2015)

Multifaceted CK2 in malignant and healthy T cells
por: Ribeiro, Sérgio T., et al.
Publicado: (2017)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021)

Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities
por: Parakh, Sagun, et al.
Publicado: (2021)

Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges
por: Poh, Ashleigh R., et al.
Publicado: (2021)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)

An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2
por: Jose, Joachim, et al.
Publicado: (2017)

Microglia: Newly discovered complexity could lead to targeted therapy for neonatal white matter injury and dysmaturation
por: Volpe, J.J.
Publicado: (2019)

Macro-CK and CK-BB Contributing to Sham CK-MB Elevation
por: Wada, Yuki, et al.
Publicado: (2017)

IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
por: Eissmann, Moritz F., et al.
Publicado: (2019)

Longitudinal quantification of mouse gastric tumor organoid viability and growth using luminescence and microscopy
por: Morrow, Riley J., et al.
Publicado: (2023)

Cathepsin B Dipeptidyl Carboxypeptidase and Endopeptidase Activities Demonstrated across a Broad pH Range
por: Yoon, Michael C., et al.
Publicado: (2022)

“I’ve got a spring in my step” participants experience of action observation therapy and eccentric exercises, a telehealth study for mid-portion Achilles Tendinopathy: a qualitative study
por: Ryan, Deirdre, et al.
Publicado: (2023)

Occupational Therapy Services in School-Based Practice: A Pediatric Occupational Therapy Perspective from Ireland
por: O'Donoghue, Carol, et al.
Publicado: (2021)

CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
por: Chua, Melissa M.J., et al.
Publicado: (2017)

Targeting Casein Kinase 1 (CK1) in Hematological Cancers
por: Janovská, Pavlína, et al.
Publicado: (2020)

Efficient development of stable and highly functionalised peptides targeting the CK2α/CK2β protein–protein interaction
por: Iegre, Jessica, et al.
Publicado: (2019)

Therapeutic targeting of CK2 in acute and chronic leukemias
por: Buontempo, F, et al.
Publicado: (2018)

A Recommendation for Revised Dose Calibrator Measurement Procedures for (89)Zr and (124)I
por: Beattie, Bradley J., et al.
Publicado: (2014)

Protein Kinase CK2—A Putative Target for the Therapy of Diabetes Mellitus?
por: Ampofo, Emmanuel, et al.
Publicado: (2019)

Mining CK2 in Cancer
por: Ortega, Charina E., et al.
Publicado: (2014)

CK2 and the Hallmarks of Cancer
por: Firnau, May-Britt, et al.
Publicado: (2022)

Clinical neurologic indices of toxicity in animals.
por: O'Donoghue, J L
Publicado: (1996)

BCL-XL is an actionable target for treatment of malignant pleural mesothelioma
por: Arulananda, Surein, et al.
Publicado: (2020)

Education-based, lifestyle intervention programs with unsupervised exercise improve outcomes in adults with metabolic syndrome. A systematic review and meta-analysis
por: Peiris, Casey L., et al.
Publicado: (2021)

Utility of CK8, CK10, CK13, and CK17 in Differential Diagnostics of Benign Lesions, Laryngeal Dysplasia, and Laryngeal Squamous Cell Carcinoma
por: Boricic, Novica, et al.
Publicado: (2022)

Targeting IL-11 signaling in colon cancer
por: Ernst, Matthias, et al.
Publicado: (2013)

Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma
por: Arulananda, Surein, et al.
Publicado: (2021)

Physician Perceptions of the FDA’s Breakthrough Therapy Designation: An Update
por: Paquin, Ryan S, et al.
Publicado: (2022)

An Immunohistochemical Expression of CK5/6, CK7, and CK20 on Cell Blocks in Metastatic Cervical Lymphadenopathy
por: Kaur, Amanpreet, et al.
Publicado: (2022)

A Conceptual Analytics Model for an Outcome-Driven Quality Management Framework as Part of Professional Healthcare Education
por: Hervatis, Vasilis, et al.
Publicado: (2015)

CK2—An Emerging Target for Neurological and Psychiatric Disorders
por: Castello, Julia, et al.
Publicado: (2017)

Targeting protein kinase CK2 in the treatment of cholangiocarcinoma
por: Jayaraman, Padma-Sheela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hu6ckvof74r42mmuo39a3o5d56